Highlighting innovation in action

Paige is in the news. See what we have been up to.

Latest News

University Medical Center Utrecht Partners with Paige to Conduct Health Economics Study and to Evaluate AI in Clinical Setting

Latest News

Dr. Perincheri of Yale Medicine Shares Live Assessment of Paige Prostate on Core Biopsies

Latest News

Paige and the University of Oxford shed light on how patients feel about digital pathology and AI

News

News November 16, 2022

University Medical Center Utrecht Partners with Paige to Conduct Health Economics Study and to Evaluate AI in Clinical Setting

...

News November 02, 2022

Dr. Perincheri of Yale Medicine Shares Live Assessment of Paige Prostate on Core Biopsies

...

News October 25, 2022

Paige and the University of Oxford shed light on how patients feel about digital pathology and AI

...

News October 13, 2022

Dr. Retamero Discusses How AI Tools Can Help Pathologists Better Diagnose Breast Cancer

...

Press Release September 22, 2022

Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption

...

News September 08, 2022

Drs. Eloy and Bryson Validate Paige Prostate Diagnostic AI in Clinical Setting

...

Press Release August 11, 2022

Paige Announces Partnership with Sonora Quest Laboratories to Accelerate Precision Diagnostics for Patients Across Arizona

...

Press Release June 23, 2022

Paige Answers Call to Better Identify Breast Cancer Patients with Low Expression of HER2

...

Press Release June 15, 2022

Paige Announces Collaboration with Janssen to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings

...

News June 01, 2022

From Slides to Pixels

...

News, Press Release May 23, 2022

Partnership set to revolutionise detection of cancer through Artificial Intelligence

...

Press Release May 12, 2022

Paige AI Solution for Prostate Cancer Biomarker Detection Receives CE-IVD and UKCA Marks

...

Press Release April 07, 2022

Ultivue Announces Co-Marketing and Co-Development Collaboration with Paige for AI-Powered Biomarker Imaging Solutions for Precision Medicine

...

Press Release April 04, 2022

Paige Announces Expansion of Scientific Advisory Board

Announcing several additions to the Scientific Adv...

Press Release March 22, 2022

Paige Launches AI Software to Enable Accurate and Efficient Detection of Breast Cancer Metastases in Lymph Nodes

Determining whether cancer in the breast has sprea...

Press Release February 17, 2022

Paige and Flagship Biosciences Announce Partnership to Expand Access to Immuno-Oncology BiomarkerAnalysis Tools

Partnership to provide access to Flagship’s AI-a...

Press Release February 15, 2022

Paige and Mindpeak Announce Partnership to Expand Access to Industry - Leading AI Software for Breast Cancer

Companies partner to bring robust AI capabilities ...

News February 03, 2022

2021 Year End Review

The past year was a landmark year for Paige’s gr...

Press Release February 01, 2022

Paige Announces New UK Study to Evaluate AI Tools That Determine Spread of Cancer Beyond Breast Tissue

Study led by Guy’s and St Thomas’ NHS Foundati...

News January 31, 2022

Inform Diagnostics Leverages the Power of Digital Pathology with the Launch of Paige FullFocus Viewer

Inform Diagnostics, a leading national pathology l...

Press Release January 12, 2022

Paige Announces Executive Leadership Appointments

Andy Moye, Ph.D., to serve as Chief Executive Offi...

Press Release December 15, 2021

University of Louisville Health Adopts Paige AI-enabled Cancer Detection Software for Enhanced Cancer Detection

University of Louisville Health is one of the firs...

Press Release December 08, 2021

Paige Named to the 2021 CB Insights Digital Health 150–List of Most Innovative Digital Health Startups

Paige recognized for achievements in Computer-Aide...

Press Release December 02, 2021

National Institute for Health and Care Excellence Publishes Medtech Innovation Briefing on Paige Prostate

NICE conducted a systematic literature review and ...

Press Release September 22, 2021

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

With a projected 60 percent increase in the number...

Press Release June 21, 2021

Paige, Oxford University and UK NHS Partners Win Government Funding to Evaluate Paige Prostate Cancer Detection System

Under the award, leaders in uropathology at Oxford...

News June 16, 2021

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

Paige Prostate automatically detects and highlight...

Press Release June 02, 2021

Dr. David Klimstra joins Paige as Chief Medical Officer

“We are thrilled to welcome Dr. Klimstra into hi...

Press Release May 25, 2021

Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care

The collaboration involves analysis using Paige's ...

Press Release May 12, 2021

Inform Diagnostics and Paige Enter Collaboration to Integrate Digital Solutions with Anatomic Pathology Diagnostics

The FDA-cleared and CE-marked Paige Platform featu...

Press Release April 29, 2021

Paige and Grupo Oncoclinicas Publish Study Demonstrating Paige Prostate May Improve Pathology Workflow in Real-World Setting

Results showed 100% sensitivity and reduced time t...

Press Release April 22, 2021

Paige and Leica Biosystems Partner to Expand Access to Computational Pathology Products for Pathology and Oncology Research

Companies to offer Paige’s machine learning tech...

Press Release March 30, 2021

Paige Announces Appointment of Andy Moye as Chief Commercial Officer and Dr. Juan Antonio Retamero as Medical Director

Dr. Moye is a seasoned commercial leader and corpo...

Press Release March 17, 2021

Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software

Under the terms of this agreement, Epredia has bee...

Press Release March 09, 2021

Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million

Additional investors in the Series C round include...

Press Release March 08, 2021

Fierce Medtech names Paige as one of its “Fierce 15” companies of 2020

An internationally recognized daily report reachin...

Press Release January 14, 2021

Paige Announces Series C Funding Round of $100Million to Accelerate Transformation of Digital Pathology

The Series C financing was led by Casdin Capital...

Press Release December 08, 2020

Paige Achieves CE Marks for Breast Cancer Detection and Prostate Cancer Grading and Quantification AI-based Digital Diagnostics

Achievements build on company’s CE marks for fir...

Press Release November 18, 2020

Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer

Co-development program will utilize next-generatio...

Press Release July 21, 2020

Paige Receives FDA Clearance for the FullFocus™ Viewer for Digital Pathology

Lack of interoperability, intensive capital requir...

Press Release July 13, 2020

Paige Secures Additional $15M from Goldman Sachs, for a Total Series B Funding Round of $70M

The funding will be added to previously announced ...

Press Release April 23, 2020

Paige Secures Additional Investment from Goldman Sachs Towards Series B Funding Round

It has received additional funding from Goldman Sa...

Press Release January 14, 2020

Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services

Invicro is a global provider of imaging biomarkers...

Press Release December 18, 2019

Paige Raises $45 Million To Accelerate the Future of Pathology

Healthcare Venture Partners brought the largest co...

Press Release December 05, 2019

Philips and Paige Team Up To Bring Artificial Intelligence (AI) to Clinical Pathology Diagnostics

Pathologists play a crucial role in the detection ...

Press Release November 12, 2019

Paige Announces First-Ever CE Mark for Deep Learning in Pathology

With CE Mark, these solutions will be available to...

News October 02, 2019

Paige Is Named as One of CB Insights Most Promising Digital Health Startups

In addition to listing Paige as one of their most ...

News April 24, 2019

A Real PAIGE-Turner

Revolutionizing cancer diagnostics through computa...

Press Release March 07, 2019

FDA Grants Breakthrough Designation to Paige

The FDA’s Breakthrough Device designation is gra...

News February 13, 2019

Paige.AI Founder, Thomas Fuchs, Featured Amongst the “Top 100 AI Leaders in Drug Discovery and Advanced Healthcare.”

Over the last several years, the pharmaceutical an...

News February 06, 2019

Paige.AI is Featured in the CB Insights’ 2019 List of 100 Most Promising AI Startups!

The CB Insights research team selected the 100 sta...

Press Release January 16, 2019

Igneous Partners with Paige.AI To Enhance Industry Leading Compute Cluster for Healthcare AI

Igneous, Inc. today announced that PAIGE, a new co...

Press Release May 21, 2018

Paige.AI Wins the Crain’s New York Heritage Research Investigators in Translational Medicine Award

Mary Kramer, Group Publisher, Chicago, Cleveland, ...

News October 01, 2017

Launch of the Warren Alpert Center for Digital and Computational Pathology

The Warren Alpert Center for Digital and Computati...

News July 06, 2017

How AI Detectives Are Cracking Open the Black Box of Deep Learning

Science produced a beautiful video explaining the ...

News June 27, 2017

A Reality Check for IBM’s AI Ambitions

Paige.AI’s founder gave an interview about the c...

News May 09, 2017

NVIDIA's AI in Healthcare Summit 2017

Paige.AI’s founder, Thomas Fuchs, was invited to...

Search News

Reset

Other Resources

Stay Updated

Sign up to receive the most updated news in the field of digital and computational pathology

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
__hssrc	session	This cookie is set by Hubspot whenever it changes the session cookie. The __hssrc cookie set to 1 indicates that the user has restarted the browser, and if the cookie does not exist, it is assumed to be a new session.
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
__hssc	30 minutes	HubSpot sets this cookie to keep track of sessions and to determine if HubSpot should increment the session number and timestamps in the __hstc cookie.
__hstc	5 months 27 days	This is the main cookie set by Hubspot, for tracking visitors. It contains the domain, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_UA-144495997-2	1 minute	A variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
hubspotutk	5 months 27 days	HubSpot sets this cookie to keep track of the visitors to the website. This cookie is passed to HubSpot on form submission and used when deduplicating contacts.